Hoth Therapeutics, Inc. 8-K

What Happened

• On May 15, 2026, Rocket One Inc., a newly formed subsidiary of Hoth Therapeutics, entered into two license agreements with the Virginia Commonwealth University Intellectual Property Foundation (VCU). The agreements grant Rocket One an exclusive, royalty-bearing license to certain patents and a non‑exclusive, royalty-bearing license to technical information for use in the defined Field of Use: commercial use for data centers and artificial intelligence.
• On May 19, 2026, Hoth issued a press release stating its intent to change its name to “Rocket One, Inc.” and to restructure to pursue opportunities in AI infrastructure, next‑generation semiconductors, and ultra‑low‑power AI computing.

Key Details

• Effective date of the license agreements: May 15, 2026; Field of Use: data centers and artificial intelligence.
• Royalty structure: mid single‑digit % of Net Sales for products/services covered by Licensed Patents; low single‑digit % of Net Sales for items covered by Licensed Technical Information; low double‑digit % of Sublicensing Revenue.
• Payments and costs: minimum annual payments range from low five figures to mid five figures (increasing over time); one agreement included a low five‑digit upfront payment; Rocket One will reimburse VCU for reasonable legal expenses to file, prosecute, and maintain the Licensed Patents.
• Term: each license runs until the later of (a) expiration of the last Licensed Patent or (b) 15 years after first commercial sale of a Licensed Product or Service, unless earlier terminated per the agreements.

Why It Matters

• The agreements give Hoth’s new subsidiary exclusive patent rights and access to technical information specifically for AI and data‑center applications—legal rights that would be necessary to develop or commercialize related products or services in that Field of Use.
• The royalty and minimum‑payment obligations create ongoing costs tied to any future sales or sublicensing of the technology; investors should note these contractual expenses (including patent prosecution reimbursements) when evaluating future margins and cash flow from licensed products.
• The announced name change and stated restructuring indicate a formal strategic shift toward AI infrastructure and semiconductor technology; the licensing deals are a concrete step toward securing IP needed for that direction.